Anti-endothelial cell antibodies in Behçet's disease

Clinical and Experimental Rheumatology

Volumn 21, Issue 4 SUPPL. 30, 2003, Pages

  Dinc, Ayhan ^a,d   Takafuta, Toshiro ^a   Jiang, Dongsheng ^a   Melikoglu, Melike ^b   Saruhan Direskeneli, Guher ^c   Shapiro, Sandor S ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Anti endothelial antibodies; Beh et's disease; Endothelium

Indexed keywords

CELL ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; REAGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BEHCET DISEASE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; DATA ANALYSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; ROOM TEMPERATURE; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC); UMBILICAL VEIN;

ADULT; AUTOANTIBODIES; BEHCET SYNDROME; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 0141781091     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BARNES CG, YAZICI H: Behçet's syndrome. Rheumatology 1999; 38: 1171-4.
2. YAZICI H, YURDAKUL S, HAMURYUDAN V: Behçet's syndrome. Curr Opinion Rheumatol 1999; 11: 53-7.
3. YAZICI H, HEKIM N, OZBAKIR F et al.: Von Willebrand factor in Behçet's syndrome. J Rheumatol 1987; 14: 305-6.
4. KANSU E, SAHIN G, SAHIN F, SIVRI B, SAYEK I. BATMAN F: Impaired prostacyclin synthesis by vessel walls in Behçet's disease. Lancet 1986; 2: 1154.
5. OREM A, VANIZOR B, CIMSIT G, KIRAN E, DEGER O, MALKOC M: Decreased nitric oxide production in paltients with Behçet's disease. Dermatology 1999; 198: 33-6.
6. TSUKADA N, TANAKA Y, YANAGISAWA N: Autoantibodies to brain endothelial cells in the sera of patients with human T-lymphotropic virus type I-associated myelopathy and other demyelinating disorders. J Neurol Sci 1989; 90: 33-42.
7. PIVETTI-PEZZI P, PRIORI R, CATARINELLI G et al.: Markers of vascular injury in Behçet's disease associated with retinal vasculitis. Ann Ophthalmol 1992; 24: 411-4.
8. AYDINTUG AO, TOKGOZ G, D'CRUZ DP et al.: Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol 1993; 67: 157-62.
9. DIRESKENELI H, KESER G, D'CRUZ D et al.: Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatol 1995; 14: 55-61.
10. CERVERA R, NAVARRO M, LOPEZ-SOTO A et al.: Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity. Ann Rheum Dis 1994; 53: 265-7.
11. TRIOLO G, ACCARDO-PALUMBO A, TRIOLO G, CARBONE MC, FERRANTE A, GIARDINA E: Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: Moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. Clin Immunol 1999; 91: 330-7.
12. LEE KH, BANG D, CHOI ES, CHUN WH, LEE ES, LEE S: Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease. Arch Dermatol Res 1999; 291: 374-81.
13. RONDA N, GATTI R, ORLANDINI G, BORGHETTI A: Binding and internalization of human IgG by living cultured endothelial cells. Clin Exp Immunol 1997; 109: 211-6.
14. REVELEN R, BORDRON A, DUEYMES M, YOUINOU P, ARVIEUX J: False positivity in a cyto-ELISA for anti-endothelial cell antibodies caused by heterophile antibodies to bovine serum proteins. Clin Chem 2000; 46: 273-8.
15. YOUINOU P, MERONI PL, KHAMASHTA MA, SHOENFELD Y: A need for standardization of the anti-endothelial cell antibody test. Immunol Today 1995; 16: 363-4.
16. International Study Group for Behçet's Disease: Criteria for diagnosis of Bedçet's disease. Lancet 1990; 335: 1078-80.
17. JAFFE EA, NACHMAN RL, BECKER CG, MINICK CR: Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-56.
18. BELIZNA C, TERVAERT JW: Specificity, pathogenecity, and clinical value of anti-endothelial cell antibodies. Semin Arthritis Rheum 1997; 27: 98-109.
19. POBER JS, COTRAN RS: Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-51.
20. ZOELLNER H, HOFLER M, BECKMANN R et al.: Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 1996; 109: 2571-80.
21. RONDA N, LEONARDI S, ORLANDINI G et al.: Natural anti-endothelial cell antibodies (AECA). J Autoimmun 1999; 13: 121-7.
22. COMBES V, SIMON AC, GRAU GE et al.: In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.
23. AYDINTUG AO, TOKGOZ G, OZORAN K, DUZGUN N, GURLER A, TUTKAK H: Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease. Rheumatol Int 1995; 15:75-8.